Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis.

Journal of Alzheimer's disease : JAD - 1 Dec 2025

Ye Hongyu, Zhuang Caixiang, Jin Ziyang, Hu Yuwen, He Jianghai, Yu Qingxiang, Hu Haoxiang, Zheng Yanyan

Abstract excerpt

BackgroundCurrent therapeutic strategies for Alzheimer's disease (AD) demonstrate limited efficacy in decelerating disease progression, underscoring an exigent need for the development of more potent disease-modifying therapeutics.ObjectiveThe primary aim of this research was to identify novel therapeutic targets to improve AD prognosis.MethodsFirst, we conducted a meta-analysis of brain tissue transcriptome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Mendelian Randomization Analysis

Share to Multiomics

Share to Polymorphism, Single Nucleotide

Share to Protein Interaction Maps

Share to Transcriptome

Source

Identifiers

PMID: 41105597
DOI: 10.1177/13872877251385244

Genes

VEGFB
CD3E
GIPR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis.PMID 41105597Read ↗

An Integrative Network-based Analysis Reveals Gene Networks, Biological Mechanisms, and Novel Drug Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

Genome-wide prediction and integrative functional characterization of Alzheimer’s disease-associated genesSemantic proximity Read ↗

Identification of potential drug targets for Alzheimer's disease from genetic insights: A Mendelian randomization study.Semantic proximity Read ↗

Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer's disease.Semantic proximity Read ↗

Integrated Bioinformatics and Ensemble Learning Reveal Diagnostic Modeling and Drug Discovery in Alzheimer’s DiseaseSemantic proximity Read ↗

A Continuous Extension of Gene Set Enrichment Analysis using the Likelihood Ratio Test Statistics Identifies VEGF as a Candidate Pathway for Alzheimer’s diseaseSemantic proximity Read ↗

Identification of Vascular Genes Differentially Expressed in the Brain of Patients with Alzheimer's Disease.Semantic proximity Read ↗

Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer's DiseaseSemantic proximity Read ↗

Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer's Disease.Semantic proximity Read ↗

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer’s Disease via ITGA5Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.